Efficacy and safety of anticoagulants in liver cirrhosis patients with portal vein thrombosis: A meta-analysis

Yao, 2005, Current research of hepatic cirrhosis in China, World J Gastroenterol, 11, 617, 10.3748/wjg.v11.i5.617 Schuppan, 2008, Liver cirrhosis, Lancet (London, England), 371, 838, 10.1016/S0140-6736(08)60383-9 Fimognari, 2008, Portal vein thrombosis in liver cirrhosis, Intern Emerg Med, 3, 213, 10.1007/s11739-008-0128-0 Tsochatzis, 2010, Systematic review: portal vein thrombosis in cirrhosis, Aliment Pharmacol Ther, 31, 366, 10.1111/j.1365-2036.2009.04182.x Zocco, 2009, Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development, J Hepatol, 51, 682, 10.1016/j.jhep.2009.03.013 Tripodi, 2011, Hypercoagulability in cirrhosis: causes and consequences, J Thromb Haemost: JTH, 9, 1713, 10.1111/j.1538-7836.2011.04429.x Hoekstra, 2009, Vascular liver disorders (II): portal vein thrombosis, Neth J Med, 67, 46 EASL Clinical Practice Guidelines, 2016, Vascular diseases of the liver, J Hepatol, 64, 179, 10.1016/j.jhep.2015.07.040 de Franchis, 2015, Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension, J Hepatol, 63, 743, 10.1016/j.jhep.2015.05.022 Condat, 2000, Recent portal or mesenteric venous thrombosis: increased recognition and frequent recanalization on anticoagulant therapy, Hepatology, 32, 466, 10.1053/jhep.2000.16597 Delgado, 2012, Efficacy and safety of anticoagulation on patients with cirrhosis and portal vein thrombosis, Clin Gastroenterol Hepatol, 10, 776, 10.1016/j.cgh.2012.01.012 Qi, 2014, Management of portal vein thrombosis in liver cirrhosis, Nat Rev Gastroenterol Hepatol, 11, 435, 10.1038/nrgastro.2014.36 Berzigotti, 2014, Imaging in clinical decision-making for portal vein thrombosis, Nat Rev Gastroenterol Hepatol, 11, 308, 10.1038/nrgastro.2013.258 Higgins, 2011, The Cochrane Collaboration's tool for assessing risk of bias in randomised trials, BMJ (Clin. Res. Ed.), 343, d5928, 10.1136/bmj.d5928 Wang, 2013, PNPLA3 RS738409 polymorphism in association with the susceptibility of alcoholic liver disease: a meta-analysis, Ann Nutr Metab, 63, 381 Jin, 2012, Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis B-related fibrosis: a leading meta-analysis, BMC Gastroenterol, 12 Friedrich-Rust, 2008, Performance of transient elastography for the staging of liver fibrosis: a meta-analysis, Gastroenterology, 134, 960, 10.1053/j.gastro.2008.01.034 Zelniker, 2019, SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials, Lancet, 393, 31, 10.1016/S0140-6736(18)32590-X Younossi, 2016, Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes, Hepatology, 64, 73, 10.1002/hep.28431 Francoz, 2005, Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation, Gut, 54, 691, 10.1136/gut.2004.042796 Senzolo, 2012, Prospective evaluation of anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis, Liver Int, 32, 919, 10.1111/j.1478-3231.2012.02785.x Chung, 2014, Safety, efficacy, and response predictors of anticoagulation for the treatment of nonmalignant portal-vein thrombosis in patients with cirrhosis: a propensity score matching analysis, Clin Mol Hepatol, 20, 384, 10.3350/cmh.2014.20.4.384 Tandoi, 2014, Optimizing results of liver transplantation with graft from HBcAb positive donor, Digest Liver Dis, 46 Chen, 2016, Efficacy and safety of anticoagulation in more advanced portal vein thrombosis in patients with liver cirrhosis, Eur J Gastroenterol Hepatol, 28, 82, 10.1097/MEG.0000000000000482 Wang, 2016, Is post-TIPS anticoagulation therapy necessary in patients with cirrhosis and portal vein thrombosis? A randomized controlled trial, Radiology, 279, 943, 10.1148/radiol.2015150369 Noronha Ferreira, 2019, Anticoagulation in cirrhosis and portal vein thrombosis is safe and improves prognosis in advanced cirrhosis, Dig Dis Sci, 64, 2671, 10.1007/s10620-019-05572-z Ai, 2020, Efficacy and safety study of direct-acting oral anticoagulants for the treatment of chronic portal vein thrombosis in patients with liver cirrhosis, Eur J Gastroenterol Hepatol, 10.1097/MEG.0000000000001846 Ponziani, 2012, What we should know about portal vein thrombosis in cirrhotic patients: a changing perspective, World J Gastroenterol, 18, 5014, 10.3748/wjg.v18.i36.5014 DeLeve, 2009, Vascular disorders of the liver, Hepatology, 49, 1729, 10.1002/hep.22772 Northup, 2008, Hypercoagulation and thrombophilia in liver disease, J Thromb Haemost: JTH, 6, 2, 10.1111/j.1538-7836.2007.02772.x Caldwell, 2006, Coagulation disorders and hemostasis in liver disease: pathophysiology and critical assessment of current management, Hepatology, 44, 1039, 10.1002/hep.21303 Kwon, 2018, Low-molecular-weight heparin treatment for portal vein thrombosis in liver cirrhosis: efficacy and the risk of hemorrhagic complications, Thromb Res, 163, 71, 10.1016/j.thromres.2018.01.032 Condat, 2001, Current outcome of portal vein thrombosis in adults: risk and benefit of anticoagulant therapy, Gastroenterology, 120, 490, 10.1053/gast.2001.21209 Cerini, 2015, Impact of anticoagulation on upper-gastrointestinal bleeding in cirrhosis. A retrospective multicenter study, Hepatology, 62, 575, 10.1002/hep.27783 Hall, 2013, Impact of anticoagulation on outcomes in acute non-cirrhotic and non- malignant portal vein thrombosis: a retrospective observational study, Hepato-gastroenterology, 60, 311 Alzubaidi, 2019, Current concepts in portal vein thrombosis: etiology, clinical presentation and management, Abdom Radiol (New York), 44, 3453, 10.1007/s00261-019-02174-1 Nery, 2015, Causes and consequences of portal vein thrombosis in 1,243 patients with cirrhosis: results of a longitudinal study, Hepatology, 61, 660, 10.1002/hep.27546